Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04342130 · ClinicalTrials.gov registry record · Phase 4
Brain Effects of Opiate Agonist and Antagonist
A Phase 4 study, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT04342130 is a Phase 4 study that has completed, run by University of Rochester. The registered enrollment target is 10 participants.
The verdict
NCT04342130, a Phase 4 study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
This study will look at the short-term effect of morphine on brain response to food.
Interventions
- DRUG Morphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-04-27 |
| Est. Completion | 2019-04-16 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04342130
The ClinicalTrials.gov registry entry for NCT04342130 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Morphine is the first listed.
NCT04342130 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04342130 about?
NCT04342130 is a clinical study titled "Brain Effects of Opiate Agonist and Antagonist". This study will look at the short-term effect of morphine on brain response to food.
What is the current status of trial NCT04342130?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2018-04-27. Estimated completion is 2019-04-16.
What interventions are being tested in trial NCT04342130?
The interventions under investigation include: Morphine (DRUG).
Who is sponsoring clinical trial NCT04342130?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.